Marc Goldman - Modular Medical Head Engineering
| MODD Stock | USD 1.60 0.08 4.76% |
Insider
Marc Goldman is Head Engineering of Modular Medical
| Address | 10740 Thornmint Road, San Diego, CA, United States, 92127 |
| Phone | (858) 800-3500 |
| Web | https://modular-medical.com |
Modular Medical Management Efficiency
The company has return on total asset (ROA) of (0.9477) % which means that it has lost $0.9477 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8261) %, meaning that it created substantial loss on money invested by shareholders. Modular Medical's management efficiency ratios could be used to measure how well Modular Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -1.33. The current year's Return On Capital Employed is expected to grow to -1.35. At present, Modular Medical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 4.3 M, whereas Non Currrent Assets Other are forecasted to decline to 0.00.Similar Executives
| Showing other executives | INSIDER Age | ||
| Reay Brown | Sight Sciences | N/A | |
| Craig Glynn | enVVeno Medical Corp | 63 | |
| Jesse Selnick | Sight Sciences | N/A | |
| David MD | Nexalin Technology | 62 | |
| Paul Badawi | Sight Sciences | 49 | |
| Alex Shvartsburg | LivaNova PLC | 54 | |
| Stacie Rodgers | Sight Sciences | N/A | |
| Michael Goodman | STRATA Skin Sciences | N/A | |
| Keith Simeone | STRATA Skin Sciences | N/A | |
| Chi Nguyen | Neuropace | 47 | |
| John Ordway | Sight Sciences | N/A | |
| Martha Morrell | Neuropace | 67 | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| Lindsey Little | LivaNova PLC | N/A | |
| Marco Dolci | LivaNova PLC | 62 | |
| Mark Saxton | Neuropace | 59 | |
| MBA BS | Sight Sciences | N/A | |
| Michael Favet | Neuropace | 54 | |
| Andre Marquette | Neuropace | N/A | |
| William MBA | STRATA Skin Sciences | 58 | |
| Joel Bradus | Nexalin Technology | N/A | |
Management Performance
| Return On Equity | -1.83 | ||||
| Return On Asset | -0.95 |
Modular Medical Leadership Team
Elected by the shareholders, the Modular Medical's board of directors comprises two types of representatives: Modular Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Modular. The board's role is to monitor Modular Medical's management team and ensure that shareholders' interests are well served. Modular Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Modular Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marc Goldman, Head Engineering | ||
| James Besser, Chief Officer | ||
| Paul DiPerna, President, Chairman | ||
| Kevin Schmid, Chief Officer |
Modular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Modular Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.83 | ||||
| Return On Asset | -0.95 | ||||
| Current Valuation | 55.2 M | ||||
| Shares Outstanding | 34.57 M | ||||
| Shares Owned By Insiders | 10.04 % | ||||
| Shares Owned By Institutions | 44.11 % | ||||
| Number Of Shares Shorted | 648.34 K | ||||
| Price To Book | 8.40 X | ||||
| EBITDA | (17.1 M) | ||||
| Net Income | (17.47 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Modular Medical is a strong investment it is important to analyze Modular Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Modular Medical's future performance. For an informed investment choice regarding Modular Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Modular Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Modular Stock refer to our How to Trade Modular Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Modular Medical. If investors know Modular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Modular Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Return On Assets (0.95) | Return On Equity (1.83) |
The market value of Modular Medical is measured differently than its book value, which is the value of Modular that is recorded on the company's balance sheet. Investors also form their own opinion of Modular Medical's value that differs from its market value or its book value, called intrinsic value, which is Modular Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Modular Medical's market value can be influenced by many factors that don't directly affect Modular Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Modular Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Modular Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Modular Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.